Half Title Page.
List of Contributors.
Etiology, Pathology, and Tumor Biology.
1: Population Screening for Prostate Cancer and Early Detection.
2: Inflammation and Infection in the Etiology of Prostate Cancer.
3: Androgen Receptor.
4: Novel Research on Fusion Genes and Next-Generation Sequencing.
5: Should Gleason Score 6 Still Be Called Cancer?.
6: High Grade Prostatic Intraepithelial Neoplasia and Atypical Glands.
7: Prostate Cancer in the Elderly.
8: Prostate Cancer and Other Primary Malignancies.
9: Biopsy Prophylaxis, Technique, Complications, and Repeat Biopsies.
10: Total and Free PSA, PCA3, PSA Density and Velocity.
11: Imaging in Localized Prostate Cancer.
Genetic Susceptibility And Hereditary Predisposition, Screening, And Counseling.
12: Prostate Cancer Prevention: Strategies and Realities.
13: Prostate-Specific Antigen Screening Guidelines.
14: Cancer of the Prostate: Incidence in the USA.
15: International Trends in Prostate Cancer.
16: Race, Ethnicity, Marital Status, Literacy, and Prostate Cancer Outcomes in the United States.
17: Hereditary Prostate Cancer.
18: Neuroendocrine Prostate Cancer.
19: Breast and Prostate Cancers: A Comparison of Two Endocrinologic Malignancies.
Prevention of Prostate Cancer.
20: Heart Healthy = Prostate Healthy and S.A.M. are the Ideal “Natural” Recommendations for Prostate Cancer.
21: Effects of Smoking, Alcohol, and Exercise on Prostate Cancer.
22: Environmental and Occupational Exposures and Prostate Cancer.
23: Level-1 Data from the REDUCE Study and the PCPT Data.
24: Decision Support for Low-Risk Prostate Cancer.
25: Active Surveillance: Rationale, Patient Selection, Follow-up, and Outcomes.
26: Preoperative Risk Assessment.
27: Is Surgery Still Necessary for Prostate Cancer?.
28: Indications for Pelvic Lymphadenectomy.
29: The Surgical Anatomy of the Prostate.
30: Radical Retropubic Prostatectomy.
31: Radiation-Resistant Prostate Cancer and Salvage Prostatectomy.
32: Postradical Prostatectomy Incontinence.
33: Prognostic Significance of Positive Surgical Margins and Other Implications of Pathology Report.
34: Open Versus Robotic Prostatectomy.
35: The Technique of Robotic Nerve-Sparing Prostatectomy.
36: Anterior Approach to Robotic Radical Prostatectomy.
37: Posterior Approach to Robotic-Assisted Laparoscopic Radical Prostatectomy.
38: The Technique of Robotic Nerve Sparing Prostatectomy. - Extraperitoneal Approach.
39: Clinical and Pathologic Staging of Prostate Cancer.
40: Management of Bladder Neck Contracture in the Prostate Cancer Survivor.
41: Reimbursement for Prostate Cancer Treatment.
42: Fundamentals of Radiation Treatment for Prostate Carcinoma – Techniques, Radiation Biology, and Evidence Base.
43: Radiation with Hormonal Therapy.
44: Brachytherapy for Prostate Cancer: An Overview.
45: Intensity Modulated Radiotherapy and Image Guidance.
46: Proton Beam Therapy.
47: Radiotherapy After Radical Prostatectomy: Adjuvant Versus Salvage Approach.
48: Emerging Modalities in Radiation Therapy for Prostate Cancer.
49: Management of PSA Recurrences After Radical Prostatectomy.
50: Salvage Therapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy.
51: Management of Locally Advanced (Nonmetastatic) Prostate Cancer.
Advanced Prostate Cancer.
52: Androgen Deprivation Therapy: Appropriate Patients, Timing to Initiate ADT, and Complications.
53: Bone Health in Prostate Cancer.
54: Castration Resistant Prostate Cancer: Role of Chemotherapy.
55: Antiandrogen Monotherapy in the Treatment of Prostate Cancer.
56: Sipuleucel-T – A Model for Immunotherapy Trial Development.
57: Second-Line Hormonal for Castrate-Resistant Prostate Cancer.
Cryoablation, Hifu and Focal Therapy.
58: Salvage Cryoablation of the Prostate.
59: High-Intensity Focused Ultrasound.
60: Focal Therapy for Prostate Cancer.
61: Quality of Life: Impact of Prostate Cancer and Its Treatment.
62: Impact of Prostate Cancer Treatments on Sexual Health.
63: Coding and Billing for Diagnosis and Treatment of Prostate Cancer.
64: Health Policy for Prostate Cancer: PSA Screening as Case Study.
65: Legal Implications of Prostate Cancer Screening.
New Horizons for Prostate Cancer.
66: New Markers for Prostate Cancer Detection and Prognosis.
67: Testosterone Therapy in Hypogonadal Men with Prostate Cancer.